11.05.2015 • NewsAir ProductsappointmentDow Chemicals

Peter Wilkes New Managing Director of Biesterfeld Spezialchemie

Peter Wilkes, Managing Director of Biesterfeld Spezialchemie since May 2015
Peter Wilkes, Managing Director of Biesterfeld Spezialchemie since May 2015

Peter Wilkes (54) has been appointed as Managing Director of Biesterfeld Spezialchemie next to Dr. Nicole Hamelau with effect of May 1, 2015. Wilkes is responsible for the further strategic development and the operative business of the company and its subsidiaries. He is the successor of Thomas Arnold, who assumed the position of CEO of Biesterfeld AG on April 1, 2015. Wilkes holds a degree in economics and earned a Master of Business Administration from the University of Chicago, Illinois, USA. With previous management positions at companies like Dow Chemicals, Air Products and Chemicals, and Kolb, Peter Wilkes has gained over 25 years of international experience in the increasingly globally oriented specialty chemical industry.

„I am looking forward to this new challenge", commented Peter Wilkes the appointment. „Biesterfeld is a very successful company with a long tradition and a strong potential for future growth. Together with our suppliers and customers we would like to shape this future."

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.